In this free webinar, gain insight into why US-based biopharmaceutical manufacturing is strategically advantageous. Attendees will learn how complicated tech-transfers...
The new AI-Assistant, Sage, will build on the Foundation's ability to connect with the 3.4 million people living with epilepsy...
In this free webinar, learn how to harness integrated functional multi-omics to enhance translational confidence and de-risk early-stage drug development...
Skyhawk Therapeutics enters into an option agreement to grant Merck KGaA, Darmstadt, Germany, exclusive global rights to drug candidates pursued...
New $43M investment accelerates Medallion's AI-powered platform and launches CredAlliance™, a first-of-its-kind credentialing clearinghouse designed to eliminate redundant verification and...
Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Bronchiectasis ORLANDO, FL / ACCESS Newswire /...
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated with Percutaneous Ablation and Palliative Radiation Therapy WASHINGTON, D.C. /...
Live results announced today in Melbourne at HIC 2025, Australia's largest digital health and health informatics industry gathering MELBOURNE, AU...
Powered by OpenAI's Reinforcement Fine-Tuning technology, this first-in-class AI copilot delivers real-time, patient-specific, evidence-based insights, directly within the EHR, underpinned...
MESA, ARIZONA / ACCESS Newswire / August 18, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) recently announced that its...
North Bergen, New Jersey--(Newsfile Corp. - August 18, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the "Company"), is pleased...
Initial testing results confirm psilocybin potency and process validation for potential medical grade manufacturing applicationsIrvine Labs progresses development of proprietary...
According to the NIH, Acute myocardial infarction (AMI) is a major cause of death, affecting nearly 3 million Americans each...
SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"),...
MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce the launch of SmartSupport™, a comprehensive, on-demand...
First-in-human trial of Capricor’s StealthX™ vaccine initiated under HHS’s Project NextGenTrial conducted and funded by the National Institute of Allergy...
PRESS RELEASE - 08/18/2025, 09:00 AM EDT Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development Itasca...
SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”),...
August 18, 2025 Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)...
ASHBURN, Va., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical...